Leukemia, Myelodysplasia, Transplantation
News
NCCN creates tool to aid treatment decisions
patient and her father Photo by Rhoda Baer The National Comprehensive Cancer Network (NCCN) has developed a new tool to accompany its clinical...
News
In ALL, early treatment decisions have “irrevocable” implications
News
COMP recommends orphan designations for KTE-C19
The European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has adopted positive opinions recommending orphan designation for...
Conference Coverage
CML outcomes in the age of TKIs
Major molecular response rates at 12 months were better among CML patients treated with dasatinib/nilotinib vs. imatinib for first-line therapy,...
News
Targeting a protein to improve AML treatment
Photo courtesy of VCU Massey Cancer Center Preclinical experiments have shown that blocking production of the protein CHD4 may help increase the...
News
Computerized cognitive training benefits childhood cancer survivors
Conklin and Jason Ashford Photo courtesy of St.
Conference Coverage
CML: Select TKI based on comorbidities, monitor toxicity and adherence
CML treatment success is contingent on managing reversible early toxicity, adherence to therapy, achieving landmarks of response, and remaining...
News
Five epigenetic biomarkers define three CLL subgroups
Key clinical point: A new strategy allows CLL patients to be categorized into three epigenetic subgroups with differential clinicobiologic...
News
Cancer survivors have poor diets, study suggests
New research suggests that cancer survivors in the US may need dietary interventions to improve their health. The study showed that, overall,...
News
Haplo-HSCT appears comparable to fully matched HSCT
Photo by Chad McNeeley A retrospective study suggests that, for patients with hematologic disorders, a haploidentical hematopoietic stem cell...
News
Findings may inform design of new treatments for JMML
Image from the Salk Institute Researchers have used induced pluripotent stem cells (iPSCs) to model juvenile myelomonocytic leukemia (JMML) and...